drugset / Trial / NCT01126008

Concomitant Chemoradiotherapy (CCRT) With Weekly Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer

NCT01126008 ↗

Phase 2 Completed 44 enrolled Samsung Medical Center
NaSingle-groupOpen-labelTreatment

Summary

This phase II trial is evaluating the efficacy of concurrent chemoradiation therapy with weekly docetaxel and cisplatin combination regimen.

Timeline

Start
2009-11-16
Primary completion
2016-04-15
Completion
2016-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 20 mg/m2 —
Subject Docetaxel Small molecule 20 mg/m2 —

Indications